Formulation and Evaluation of Sustained Release Matrix Tablets of Repaglinide

  • Venkateswarlu K
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

The aim of present investigation was to formulate and evaluate the sustained release matrix tablets of Repaglinide (RPGN). These matrix tablets were prepared by wet granulation method using synthetic and natural polymers like HPMC K4M, HPMC 100M and Guar gum (GG), Carrageenan (CG), respectively. Invitro drug release studies were performed by USP dissolution apparatus type-II (paddle method) using 0.1 N HCl buffer and pH 6.8 phosphate buffer for 12 h. Amongst all the 12 formulations, formulation F12 showed maximum drug release of 97.9% for 12 h study. It was observed from the kinetic studies that all the formulations followed first order kinetics and particularly the drug release from its dosage form was fickian diffusion (F9, F12), non-fickian diffusion (F1-F8, F10-F11). Formulation F12 was subjected to stability studies and confirmed that formulation F12 was stable upto the period of 1 month.Bangladesh Pharmaceutical Journal 19(1): 92-99, 2016

Cite

CITATION STYLE

APA

Venkateswarlu, K. (2016). Formulation and Evaluation of Sustained Release Matrix Tablets of Repaglinide. Bangladesh Pharmaceutical Journal, 19(1), 92–99. https://doi.org/10.3329/bpj.v19i1.29244

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free